LIPOLIPELLA PHARMACEUTICALS INC.

Nasdaq lipella.com


$ 0.72 $ 0.01 (1.5 %)    

Tuesday, 07-May-2024 10:02:52 EDT
QQQ $ 442.15 $ -0.77 (-0.17 %)
DIA $ 395.29 $ 0.03 (0.01 %)
SPY $ 521.01 $ -0.51 (-0.1 %)
TLT $ 90.08 $ -0.23 (-0.25 %)
GLD $ 218.64 $ -1.14 (-0.52 %)
$ 0.75
$ 0.72
$ 0.00 x 0
$ 0.00 x 0
$ 0.72 - $ 0.72
$ 0.64 - $ 2.71
14,808
na
5.47M
$ -0.60
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 02-27-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-14-2023 06-30-2023 10-Q
5 05-12-2023 03-31-2023 10-Q
6 03-31-2023 12-31-2022 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 maxim-group-initiates-coverage-on-lipella-pharmaceuticals-with-buy-rating-announces-price-target-of-2

Maxim Group analyst Jason McCarthy initiates coverage on Lipella Pharmaceuticals (NASDAQ:LIPO) with a Buy rating and announc...

 lipella-pharmaceuticals-to-publish-abstract-detailing-preclinical-support-for-new-product-candidate-at-asco-2024

Lipella Pharmaceuticals Inc.

 why-sophia-genetics-shares-are-trading-lower-by-19-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expect...

 lipella-pharmaceuticals-announces-fda-clearance-of-ind-for-lp-410-for-oral-graft-versus-host-disease-advancing-clinical-pipeline

Lipella Pharmaceuticals Inc. (Nasdaq: "LIPO") ("Lipella," "our, "us" or the "Company"), a c...

 lipella-pharmaceuticals-marks-successful-first-year-with-strategic-progress-and-key-milestones-accomplished

Lipella Pharmaceuticals Inc., (NASDAQ:LIPO) ("Lipella," "our," "us" or the "Company"), a pionee...

 fda-grants-orphan-designation-for-lipellas-lp-310-drug-candidate-for-oral-graft-versus-host-disease

Lipella Pharmaceuticals' LP-310 clinical stage asset is formulated for delivering active agents to the oral cavity for dise...

 why-harley-davidson-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-thursdays-mid-day-session

Gainers

 why-owens-corning-shares-are-trading-lower-by-around-9-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed bus...

 why-microsoft-shares-are-trading-higher-here-are-20-stocks-moving-premarket

Gainers ReShape Lifesciences Inc. (NASDAQ: RSLS) shares surged 62.8% to $0.3348 in pre-market trading after gaining over 6% ...

 nasdaq-down-over-1-autoliv-raises-fy23-sales-outlook

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling over 150 points on Friday. The Dow trade...

 why-adial-pharmaceuticals-shares-are-trading-lower-by-around-20-here-are-other-stocks-moving-in-fridays-mid-day-session

Gainers XORTX Therapeutics Inc. (NASDAQ: XRTX) shares jumped 60.2% to $0.5101 after jumping 34% on Thursday.

 gold-rises-over-1-schlumberger-shares-fall-after-q3-results

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling over 1% on Friday. The Dow traded down 0.31...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION